Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) was the recipient of some unusual options trading on Wednesday. Investors bought 1,002 put options on the stock. This represents an increase of approximately 1,791% compared to the typical daily volume of 53 put options.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on MRVI. Guggenheim began coverage on Maravai LifeSciences in a report on Thursday, December 19th. They issued a “neutral” rating for the company. Royal Bank of Canada dropped their price target on shares of Maravai LifeSciences from $17.00 to $13.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. The Goldman Sachs Group lowered shares of Maravai LifeSciences from a “neutral” rating to a “sell” rating and reduced their price target for the company from $7.00 to $4.25 in a research report on Thursday, December 5th. Robert W. Baird cut their target price on Maravai LifeSciences from $10.00 to $9.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Finally, William Blair reaffirmed a “market perform” rating on shares of Maravai LifeSciences in a research note on Friday, November 8th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to the company. According to MarketBeat, Maravai LifeSciences currently has an average rating of “Hold” and an average target price of $10.28.

Insider Activity

In related news, insider Carl Hull purchased 175,000 shares of the business’s stock in a transaction on Monday, November 11th. The shares were bought at an average cost of $5.64 per share, with a total value of $987,000.00. Following the transaction, the insider now owns 175,000 shares of the company’s stock, valued at approximately $987,000. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.63% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the business. Point72 Asia Singapore Pte. Ltd. acquired a new position in Maravai LifeSciences in the 2nd quarter valued at $32,000. Venturi Wealth Management LLC acquired a new stake in Maravai LifeSciences during the third quarter worth about $47,000. Custom Index Systems LLC acquired a new position in shares of Maravai LifeSciences in the 3rd quarter valued at about $97,000. Y Intercept Hong Kong Ltd acquired a new stake in shares of Maravai LifeSciences in the third quarter worth $105,000. Finally, Headlands Technologies LLC boosted its position in Maravai LifeSciences by 205.9% during the 2nd quarter. Headlands Technologies LLC now owns 14,935 shares of the company’s stock worth $107,000 after purchasing an additional 10,053 shares during the period. Institutional investors and hedge funds own 50.25% of the company’s stock.

Maravai LifeSciences Trading Up 1.3 %

MRVI opened at $6.13 on Thursday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 9.94 and a current ratio of 10.74. The business’s 50-day simple moving average is $5.73 and its 200-day simple moving average is $7.43. The company has a market cap of $1.55 billion, a P/E ratio of -3.74 and a beta of -0.07. Maravai LifeSciences has a one year low of $4.28 and a one year high of $11.56.

Maravai LifeSciences Company Profile

Maravai LifeSciences Holdings, Inc, a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company’s products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species.